Atlas Trials

Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO)

Clinical trial NCT02605694 · WITHDRAWN

Trial details

NCT number
NCT02605694
Sponsor
SecuraBio
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2015-12-01
Primary completion
2016-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.